Abstract: The present application provides anti-IGFBP7 constructs that bind to IGFBP7 (e.g., anti-IGFBP7 antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-IGFBP7, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-IGFBP7 construct, pharmaceutical compositions containing the anti-IGFBP7 construct, and methods of using the anti-IGFBP7 construct or compositions.